Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:56 PM
Ignite Modification Date:
2025-12-24 @ 2:56 PM
NCT ID:
NCT00426959
Eligibility Criteria:
Inclusion Criteria:
* Histologically confirmed, locally confined adenocarcinoma of the prostate
* PSA of less than 10 ngmL
* Combined Gleason score 6 or less, with no individual Gleason score of 4 or 5
* The patient has decided to undergo brachytherapy at the Johns Hopkins Hospital as treatment choice for his prostate cancer
* Karnofsky Performance Status greater than 70
* Prostate volume by TRUS less than 50 cc
* International Prostate symptom score must be 18 or less
* Signed study-specific consent form prior to registration
Exclusion Criteria:
* Clinical or Pathological Lymph node involvement,
* Evidence of distant metastases
* Radical surgery for carcinoma of the prostate
* Chemotherapy or pelvic radiation therapy
* Previous transurethral resection of the prostate
* Previous or concurrent cancers other than basal or squamous cell skin cancers unless disease free for at least 5 years.
* Significant obstructive symptoms
* Major medical or psychiatric illness which, in the investigator's opinion, Hip prosthesis
* Anatomic or medical condition (such as prior abdominal perineal resection or anal stricture) which would preclude the use of TRUS Implanted device or apparatus which might obstruct visibility of the implanted sources on fluoroscopy
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Study:
NCT00426959
Study Brief:
Protocol Section:
NCT00426959